Surgical treatment of liver metastases from breast cancer

Andrea Furka, L. Halász, Zs Szentkereszty, J. Pósán, C. András, P. Sápy

Research output: Article

15 Citations (Scopus)

Abstract

Background/Aims: The resection of colorectal liver metastases is currently a well accepted and effective treatment. In the past decade liver metastases of breast cancer have been treated more frequently by surgical intervention. Methodology: The authors retrospectively studied the data of 17 operated patients, and investigated the clinical features of liver metastases, lymph node involvement of primary tumor, the indications of operations, and early and late results of the treatment. Results: The solitary metastasis and demarcated multiple metastases, which seemed (by CT scan) to be operable by Ro resection were among the surgical indications. Different segment resections, 3 laparoscopic resections and one hemihepatectomy were performed. There were no deaths in the perioperative period, though there were two minor postoperative complications in two cases. All patients received chemotherapy. By follow-up, three breast cancer patients died, whose average survival rate was 19.25 months. The other patients' average follow-up time was 15.17 months, without relapse. Conclusions: In conclusion it appears that in selected cases resection of liver metastases can be safely performed and the survival rate is reasonable.

Original languageEnglish
Pages (from-to)1416-1418
Number of pages3
JournalHepato-Gastroenterology
Volume55
Issue number85
Publication statusPublished - júl. 2008

Fingerprint

Breast Neoplasms
Neoplasm Metastasis
Liver
Therapeutics
Survival Rate
Perioperative Period
Lymph Nodes
Recurrence
Drug Therapy
Neoplasms

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Furka, A., Halász, L., Szentkereszty, Z., Pósán, J., András, C., & Sápy, P. (2008). Surgical treatment of liver metastases from breast cancer. Hepato-Gastroenterology, 55(85), 1416-1418.

Surgical treatment of liver metastases from breast cancer. / Furka, Andrea; Halász, L.; Szentkereszty, Zs; Pósán, J.; András, C.; Sápy, P.

In: Hepato-Gastroenterology, Vol. 55, No. 85, 07.2008, p. 1416-1418.

Research output: Article

Furka, A, Halász, L, Szentkereszty, Z, Pósán, J, András, C & Sápy, P 2008, 'Surgical treatment of liver metastases from breast cancer', Hepato-Gastroenterology, vol. 55, no. 85, pp. 1416-1418.
Furka A, Halász L, Szentkereszty Z, Pósán J, András C, Sápy P. Surgical treatment of liver metastases from breast cancer. Hepato-Gastroenterology. 2008 júl.;55(85):1416-1418.
Furka, Andrea ; Halász, L. ; Szentkereszty, Zs ; Pósán, J. ; András, C. ; Sápy, P. / Surgical treatment of liver metastases from breast cancer. In: Hepato-Gastroenterology. 2008 ; Vol. 55, No. 85. pp. 1416-1418.
@article{2808f496124a4860b24dc7f5a976bf54,
title = "Surgical treatment of liver metastases from breast cancer",
abstract = "Background/Aims: The resection of colorectal liver metastases is currently a well accepted and effective treatment. In the past decade liver metastases of breast cancer have been treated more frequently by surgical intervention. Methodology: The authors retrospectively studied the data of 17 operated patients, and investigated the clinical features of liver metastases, lymph node involvement of primary tumor, the indications of operations, and early and late results of the treatment. Results: The solitary metastasis and demarcated multiple metastases, which seemed (by CT scan) to be operable by Ro resection were among the surgical indications. Different segment resections, 3 laparoscopic resections and one hemihepatectomy were performed. There were no deaths in the perioperative period, though there were two minor postoperative complications in two cases. All patients received chemotherapy. By follow-up, three breast cancer patients died, whose average survival rate was 19.25 months. The other patients' average follow-up time was 15.17 months, without relapse. Conclusions: In conclusion it appears that in selected cases resection of liver metastases can be safely performed and the survival rate is reasonable.",
keywords = "Breast cancer, Liver metastasis, Liver resection, Survival rate",
author = "Andrea Furka and L. Hal{\'a}sz and Zs Szentkereszty and J. P{\'o}s{\'a}n and C. Andr{\'a}s and P. S{\'a}py",
year = "2008",
month = "7",
language = "English",
volume = "55",
pages = "1416--1418",
journal = "Acta hepato-splenologica",
issn = "0172-6390",
publisher = "H.G.E. Update Medical Publishing Ltd.",
number = "85",

}

TY - JOUR

T1 - Surgical treatment of liver metastases from breast cancer

AU - Furka, Andrea

AU - Halász, L.

AU - Szentkereszty, Zs

AU - Pósán, J.

AU - András, C.

AU - Sápy, P.

PY - 2008/7

Y1 - 2008/7

N2 - Background/Aims: The resection of colorectal liver metastases is currently a well accepted and effective treatment. In the past decade liver metastases of breast cancer have been treated more frequently by surgical intervention. Methodology: The authors retrospectively studied the data of 17 operated patients, and investigated the clinical features of liver metastases, lymph node involvement of primary tumor, the indications of operations, and early and late results of the treatment. Results: The solitary metastasis and demarcated multiple metastases, which seemed (by CT scan) to be operable by Ro resection were among the surgical indications. Different segment resections, 3 laparoscopic resections and one hemihepatectomy were performed. There were no deaths in the perioperative period, though there were two minor postoperative complications in two cases. All patients received chemotherapy. By follow-up, three breast cancer patients died, whose average survival rate was 19.25 months. The other patients' average follow-up time was 15.17 months, without relapse. Conclusions: In conclusion it appears that in selected cases resection of liver metastases can be safely performed and the survival rate is reasonable.

AB - Background/Aims: The resection of colorectal liver metastases is currently a well accepted and effective treatment. In the past decade liver metastases of breast cancer have been treated more frequently by surgical intervention. Methodology: The authors retrospectively studied the data of 17 operated patients, and investigated the clinical features of liver metastases, lymph node involvement of primary tumor, the indications of operations, and early and late results of the treatment. Results: The solitary metastasis and demarcated multiple metastases, which seemed (by CT scan) to be operable by Ro resection were among the surgical indications. Different segment resections, 3 laparoscopic resections and one hemihepatectomy were performed. There were no deaths in the perioperative period, though there were two minor postoperative complications in two cases. All patients received chemotherapy. By follow-up, three breast cancer patients died, whose average survival rate was 19.25 months. The other patients' average follow-up time was 15.17 months, without relapse. Conclusions: In conclusion it appears that in selected cases resection of liver metastases can be safely performed and the survival rate is reasonable.

KW - Breast cancer

KW - Liver metastasis

KW - Liver resection

KW - Survival rate

UR - http://www.scopus.com/inward/record.url?scp=58149389981&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149389981&partnerID=8YFLogxK

M3 - Article

C2 - 18795702

AN - SCOPUS:58149389981

VL - 55

SP - 1416

EP - 1418

JO - Acta hepato-splenologica

JF - Acta hepato-splenologica

SN - 0172-6390

IS - 85

ER -